Pfizer Inc.

Company Overview

Pfizer is a global biopharmaceutical company founded in 1849. In 2021, Pfizer reorganized its commercial operations into two business units: Biopharma and Business innovation. The biopharma unit includes three customer groups: primary care, specialty care, and oncology. The biopharma segment offers drug and vaccine products across various therapeutic areas. Business innovation consists of two units: Pfizer CentreOne and Pfizer Ignite. Pfizer CentreOne provides contract development and manufacturing organization (CDMO) services and supplies specialty active pharmaceutical ingredients. Pfizer Ignite offers strategic guidance and R&D services to innovative biotech companies.

Financial Highlights (FY 2024)

Company's Business Segments

• Biopharma : Oncology: Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak Primary Care: Internal medicine: Eliquis, the Premarin family and BMP2 Migraine: Nurtec ODT/Vydura and Zavzpret. Vaccines: Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix and Trumenba Treatment for COVID-19: Paxlovid Detection of COVID-19 and influenza: Lucira by Pfizer Specialty Care: Inflammation & immunology: Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo and Velsipity Rare disease: the Vyndaqel family, Genotropin, BeneFIX, Oxbryta, Somavert and Ngenla Hospital: Sulperazon, Zavicefta, Zithromax, Medrol and Panzyga
• Other business activities : Oncology Research and Development (ORD), Pfizer Research and Development (PRD), Corporate and other unallocated (such as digital, global real estate operations, legal, finance, human resources, worldwide public affairs, compliance and worldwide procurement, among others) and other corporate costs.